SCAN-MED. A/S. DENMARK: Financial statements 2022
CVR: 14472800
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SCAN-MED. A/S. DENMARK (CVR 14472800) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 14,713,248 and a net result of DKK 4,445,284 compared with DKK 859,738 the year before. That is an increase of 95.5% compared with the year before. Equity in the 2022 report amounted to DKK 15,088,875. The solvency ratio was 57.1%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 14,713,248
- Profit/Loss
- DKK 4,445,284
- Equity
- DKK 15,088,875
- Total Assets
- DKK 26,425,857
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 14.7M | 4.4M | 15.1M | 9 |
| 2021 | - | 7.5M | 860K | 7.2M | 8 |
| 2020 | - | 6.3M | 149K | 6.5M | 8 |
| 2019 | - | 6.1M | 133K | 6.3M | 8 |
| 2018 | - | 7.7M | 1.1M | 7.2M | 8 |
Official annual report
Keep an eye on SCAN-MED. A/S. DENMARK
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SCAN-MED. A/S. DENMARK has published its annual report for 2021. Gross profit came to DKK 7,526,625, and the net result was DKK 859,738.
About SCAN-MED. A/S. DENMARK
SCAN-MED. A/S. DENMARK is a Danish company of the type Aktieselskab based in Brabrand, founded in 1990. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named COTAS-MEDICO, DANMARK ApS and SCAN-MED, DANMARK ApS. The management consists of Kirsten Willis. The board consists of Bjørn Helmer Johnsen (chair), Kirsten Willis and Klaus Erik Johansen. The company is owned by Scan-Med A/S Norway. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,764,208 and a net result of DKK 3,439,118 compared with DKK 1,940,811 the year before. Equity in the 2025 report amounted to DKK 15,849,298.
